{
    "2018-01-30": [
        [
            {
                "time": "",
                "original_text": "沃森生物现近2亿元大宗交易",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "大宗交易",
                        "2亿元"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]医药行业周报：把握结构性机会 重点关注意创新和高端仿制",
                "features": {
                    "keywords": [
                        "医药行业",
                        "结构性机会",
                        "创新",
                        "高端仿制"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "沃森生物回应业绩变脸 称不知对赌方“心里想什么”",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "业绩变脸",
                        "对赌方"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "56家药企业绩预增超50% 沃森生物业绩变脸",
                "features": {
                    "keywords": [
                        "药企",
                        "业绩预增",
                        "50%",
                        "沃森生物",
                        "业绩变脸"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "从盈利到巨亏 沃森生物业绩变脸",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "盈利",
                        "巨亏",
                        "业绩变脸"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}